470 Results

People

  1. Morrow
    Morrow
  2. O'Reilly
    O'Reilly
  3. D'Angelica
    D'Angelica
  4. Lee
    Lee
  5. Motzer
    Motzer
  6. Abou-Alfa
    Abou-Alfa
  7. Jarnagin
    Jarnagin
  8. Gomez
    Gomez
  9. Gonen
    Gonen
  10. Hakimi
    Hakimi

Groups

  1. Department of Medicine (248)
  2. Solid Tumor Oncology Division (208)
  3. Surgery (167)
  4. Survivorship Research (88)
  5. Radiation Oncology, Department of (74)
  6. Gastrointestinal Oncology Service (71)
  7. Center for Pancreatic Cancer Research (66)
  8. Epidemiology and Biostatistics (62)
  9. Hematologic Malignancies, Division of (62)
  10. Population Sciences Research Program (61)
  1. "systemic therapy"
Formats
  1. Journal Article (324)
  2. Review (85)
  3. Editorial (26)
  4. Guidelines (17)
  5. Correspondence (7)
  6. Research Letter (7)
  7. Conference Paper (3)
  8. Book Section (1)
Groups
  1. Department of Medicine (248)
  2. Solid Tumor Oncology Division (208)
  3. Surgery (167)
  4. Survivorship Research (88)
  5. Radiation Oncology, Department of (74)
  6. Gastrointestinal Oncology Service (71)

More Groups

People
  1. Monica Morrow (23)
  2. Eileen O'Reilly (20)
  3. Michael D'Angelica (18)
  4. Nancy Lee (18)
  5. Nancy Kemeny (17)
  6. Robert Motzer (16)

More People

Years
  1. 2025 (54)
  2. 2024 (92)
  3. 2023 (56)
  4. 2022 (41)
  5. 2021 (18)
  6. 2020 (36)

More Years

Publications
  1. Annals of Surgical Oncology (29)
  2. Journal of Clinical Oncology (26)
  3. Cancer (16)
  4. International Journal of Radiation Oncology, Biology, Physics (15)
  5. Journal of the National Comprehensive Cancer Network (15)
  6. European Urology (14)

More Publications

Publishers
  1. Elsevier Inc. (106)
  2. Springer (54)
  3. Elsevier Science, Inc. (39)
  4. Wiley Blackwell (35)
  5. American Society of Clinical Oncology (32)
  6. Oxford University Press (19)

More Publishers

Results (470)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Postradical prostatectomy prostate-specific antigen outcomes after 6 versus 18 months of perioperative androgen-deprivation therapy in men with localized, unfavorable intermediate-risk or high-risk prostate cancer: Results of part 2 of a randomized phase 2 trial
    Journal Article

    McKay, R. R.; Xie, W.; Yang, X.; Acosta, A.; Rathkopf, D.; Laudone, V. P.; Bubley, G. J.; Einstein, D. J.; Chang, P.; Wagner, A. A.; more...
    Cancer (2024)

    Fulltext@MSK | Save
  • Real-world patient experience of pexidartinib for tenosynovial giant-cell tumor
    Journal Article

    Lin, F.; Kwong, W. J.; Pan, I.; Ye, X.; Dai, D.; Tap, W.
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Application of three-dimensional imaging software to map carcinomatosis in recurrent ovarian cancer
    Journal Article

    da Costa, A. G.; Albergaria, D.; Almeida, J.; Nave, M.; Oliveira, J.; Catarino, A.; Chi, D. S.; Casanova, J.
    Journal of Surgical Case Reports (2024)

    Fulltext@MSK | Save
  • Management challenges in low-grade serous ovarian cancer with a BRCA mutation
    Journal Article

    Sanchez-Lorenzo, L.; Sancho, L.; Iscar, T.; Grisham, R.; Chiva, L.
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Polatuzumab vedotin plus bendamustine and rituximab or obinutuzumab in relapsed/refractory follicular lymphoma: A phase Ib/II study
    Journal Article

    Flowers, C. R.; Matasar, M. J.; Herrera, A. F.; Hertzberg, M.; Assouline, S.; Demeter, J.; McMillan, A.; Mehta, A.; Opat, S.; Trněný, M.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Hepatic arterial infusion pump chemotherapy combined with systemic chemotherapy for borderline resectable and unresectable colorectal liver metastases: Phase II feasibility study
    Journal Article

    Krul, M. F.; Kok, N. F. M.; Osmani, H.; Buisman, F. E.; Koerkamp, B. G.; Grunhagen, D. J.; Verhoef, C.; Mostert, B.; Snaebjornsson, P.; Westerink, B.; more...
    British Journal of Surgery (2024)

    Fulltext@MSK | Save
  • Executive summary of the American Radium Society appropriate use criteria for neoadjuvant therapy for nonmetastatic pancreatic adenocarcinoma: Systematic review and guidelines
    Review

    Jethwa, K. R.; Kim, E.; Berlin, J.; Anker, C. J.; Tchelebi, L.; Abood, G.; Hallemeier, C. L.; Jabbour, S.; Kennedy, T.; Kumar, R.; more...
    American Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Hypofractionated re-irradiation for diffuse intrinsic pontine glioma
    Journal Article

    Mankuzhy, N. P.; Tringale, K. R.; Dunkel, I. J.; Farouk Sait, S.; Souweidane, M. M.; Khakoo, Y.; Karajannis, M. A.; Wolden, S.
    Pediatric Blood and Cancer (2024)

    Fulltext@MSK | Save
  • Mesothelioma: Pleural, version 1.2024: Featured updates to the NCCN Guidelines
    Guidelines

    Stevenson, J.; Ettinger, D. S.; Wood, D. E.; Aisner, D. L.; Akerley, W.; Bauman, J. R.; Bharat, A.; Bruno, D. S.; Chang, J. Y.; Chirieac, L. R.; more...
    Journal of the National Comprehensive Cancer Network (2024)

    Fulltext@MSK | Save
  • Surgical outcomes of cytoreductive nephrectomy in patients receiving systemic immunotherapy for advanced renal cell carcinoma
    Journal Article

    Reese, S. W.; Eismann, L.; White, C.; Arroyave Villada, J.; Khaleel, S.; Ostrovnaya, I.; Vazquez-Rivera, K.; Carlo, M. I.; Feldman, D.; Lee, C. H.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save